Cargando…
PD-L1 Under Regulation of miR-429 Influences the Sensitivity of Gastric Cancer Cells to TRAIL by Binding of EGFR
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has received extensive attention as a cancer therapeutic due to its high propensity for tumor targeting with minimal toxicity to healthy tissue. Gastric cancer (GCa) cells show high levels of TRAIL resistance. Epidermal growth factor re...
Autores principales: | Lv, Jinqi, Guo, Tianshu, Qu, Xiujuan, Che, Xiaofang, Li, Ce, Wang, Shuo, Gong, Jing, Wu, Peihong, Liu, Yang, Liu, Yunpeng, Xu, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387728/ https://www.ncbi.nlm.nih.gov/pubmed/32775300 http://dx.doi.org/10.3389/fonc.2020.01067 |
Ejemplares similares
-
Construction of an immune-related gene signature to predict survival and treatment outcome in gastric cancer
por: Zhang, Shuairan, et al.
Publicado: (2021) -
Positive Cross-Talk Between CXC Chemokine Receptor 4 (CXCR4) and Epidermal Growth Factor Receptor (EGFR) Promotes Gastric Cancer Metastasis via the Nuclear Factor kappa B (NF-κB)-Dependent Pathway
por: Cheng, Yu, et al.
Publicado: (2020) -
5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer Patients
por: Zhang, Min, et al.
Publicado: (2020) -
CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer
por: Zhang, Chenlu, et al.
Publicado: (2018) -
RANKL/RANK promotes the migration of gastric cancer cells by interacting with EGFR
por: Wan, Xing, et al.
Publicado: (2020)